Molecularly targeted agents: Their promise as cancer chemopreventive interventions
- 30 September 2005
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 41 (13), 2003-2015
- https://doi.org/10.1016/j.ejca.2005.06.005
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and PrognosisClinical Cancer Research, 2004
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- EGFR and cancer prognosisEuropean Journal Of Cancer, 2001
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Bcl-2 expression in malignant melanoma and its prognostic significanceEuropean Journal of Surgical Oncology, 1996
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988